CLINICAL SUPPLY MANUFACTURING ARTICLES

Logistics-transportation-GettyImages-1384980908 Vendor/Supplier Management To Maintain A Drug's Safety Profile In End-To-End Supply Chain Planning

FDA 21 CFR 211 requires vendor qualification as a part of the validation process and EU GxP requirements expect robust vendor management, and we expect regulators to issue firmer guidance sooner rather than later. Don't let your pharma/biotech fall short.

CLINICAL SUPPLY MANUFACTURING VIDEOS

See how a cutting-edge, multi-purpose isolator line delivers high-speed, precision fill/finish. This flexible technology supports a diverse range injectable therapies.

Industry experts share insights to help you mitigate supply chain risk and accelerate access to novel cell and gene therapies.

Early planning mitigates risk by avoiding stock outs and study delays, minimizing waste with optimized inventory, and forecasting demand to facilitate robust supply planning.

Expert speakers discuss current operational obstacles and explore strategic solutions to optimize a supply chain strategy in the years ahead.

CLINICAL SUPPLY MANUFACTURING RESOURCES